Is the Systemic Immune-Inflammation Index (SII) associated with depression in patients with diabetes mellitus?
The Systemic Immune-Inflammation Index may serve as an easily accessible and cost-effective biomarker for identifying depression risk in diabetic patients.
Our data suggest that SII is a risk factor for depression in patients with DM. The SII may be an easily accessible and cost-effective strategy for identifying depression in patients with DM. More studies are warranted to further analyze the role of SII in depression in diabetic patients.
Wang et al. (Fri,) studied this question.